Apyx medical corporation company news: berger montague investigates securities fraud allegations against apyx medical corp. (nasdaq: apyx); lead plaintiff deadline is august 5, 2022

Philadelphia , june 30, 2022 /prnewswire/ -- berger montague is investigating securities fraud allegations on behalf of investors who purchased the securities apyx medical corporation ("apyx" or the "company") (nasdaq: apyx) between may 12, 2021 and march 11, 2022 (the "class period"). if you purchased the securities of apyx during the class period, would like to discuss berger montague's investigation, or have questions concerning your rights or interests, please contact attorneys andrew abramowitz at aabramowitz@bm.net or (215) 875-3015, or michael dell'angelo at mdellangelo@bm.net or (215) 875-3080 or visit: https://investigations.bergermontague.com/apyx-medical-/  whistleblowers: anyone with non-public information regarding apyx is encouraged to confidentially assist berger montague's investigation or take advantage of the sec whistleblower program.
APYX Ratings Summary
APYX Quant Ranking